IntuitionLabs

14th IMPACCT RWE Summit US

Oct TBA|Boston, MA|in-person
AI & DataClinical

Conference Focus

Real-world evidence in pharma decision-making

Overview

The 14th IMPACCT RWE Summit US is a premier industry forum dedicated to the integration of real-world evidence (RWE) across the pharmaceutical product lifecycle. Organized by Hanson Wade, this summit brings together leaders from pharma, biotech, and regulatory bodies to discuss the practical application of RWE in clinical development, market access, and post-market surveillance. The event is distinguished by its focus on actionable strategies for data quality, regulatory compliance, and the utilization of advanced analytics to accelerate decision-making processes. It serves as a critical nexus for stakeholders aiming to bridge the gap between clinical trial data and real-world clinical practice.

Why Attend

Professionals should attend to gain insights into evolving regulatory expectations for RWE and to benchmark their strategies against industry peers. The summit offers unparalleled networking with cross-functional leaders, providing a strategic advantage in navigating the complexities of evidence generation. Attendees will learn how to leverage RWE to support faster drug approvals, optimize patient outcomes, and strengthen value propositions for payers and health technology assessment bodies.

Key Topics & Sessions

  • Regulatory Frameworks for RWE
  • Data Quality and Standardization
  • RWE in Clinical Trial Design
  • AI and Machine Learning in Evidence Generation
  • Patient-Centric Data Collection
  • Market Access and Payer Strategy
  • Post-Market Safety Surveillance
  • Digital Health and Wearable Data
  • Electronic Health Record (EHR) Integration
  • Evidence Synthesis and Analytics

Who Should Attend

Heads of Real-World EvidenceVP Clinical OperationsRegulatory Affairs DirectorsMarket Access ExecutivesEpidemiology LeadsData Science ManagersMedical Affairs Directors

Conference History

Organized by Hanson Wade, the IMPACCT series has established itself as a cornerstone event for RWE professionals. Over its 14-year history, the summit has evolved from niche discussions on data utility to a comprehensive platform addressing the strategic integration of RWE into global pharmaceutical R&D and commercialization strategies.

Venue & Location

Boston, MA. Specific venue details are typically finalized closer to the event date.

Related Conference Categories

This conference covers topics in the following pharma and life sciences domains. Explore more events in each category using our conference directory filters.

AI & DataAI & Machine Learning in Pharma
ClinicalClinical Operations

Resources & Links

About 14th IMPACCT RWE Summit US

14th IMPACCT RWE Summit US is a in-person event scheduled for 2026-10 (exact TBA) in Boston, MA. The conference focuses on real-world evidence in pharma decision-making. This event is categorized under AI & Machine Learning in Pharma, Clinical Operations in our conference directory.

The 14th IMPACCT RWE Summit US is a premier industry forum dedicated to the integration of real-world evidence (RWE) across the pharmaceutical product lifecycle. Organized by Hanson Wade, this summit brings together leaders from pharma, biotech, and regulatory bodies to discuss the practical application of RWE in clinical development, market access, and post-market surveillance. The event is distinguished by its focus on actionable strategies for data quality, regulatory compliance, and the utilization of advanced analytics to accelerate decision-making processes. It serves as a critical nexus for stakeholders aiming to bridge the gap between clinical trial data and real-world clinical practice.

Professionals attending conferences like 14th IMPACCT RWE Summit US gain access to cutting-edge insights, peer networking, and exposure to the latest technologies shaping the pharmaceutical and biotechnology sectors. Whether you are evaluating new vendors, seeking regulatory updates, or expanding your professional network, industry conferences remain one of the most effective ways to stay current in life sciences.

AI and machine learning continue to transform the pharmaceutical industry, from drug discovery to commercial operations. Conferences featuring AI content provide valuable exposure to real-world implementations and emerging capabilities. Explore our Pharmaceutical GenAI Tracker for a comprehensive view of AI deployments across the industry.

Looking for guidance on which conferences to attend or how to build your event strategy for 2026? Book a meeting with the IntuitionLabs team to discuss your priorities and how we can support your team.

© 2026 IntuitionLabs. All rights reserved.